Patrick B Donnelly
Stock Analyst at Citi
(3.88)
# 1,856
Out of 4,581 analysts
574
Total ratings
51.8%
Success rate
4.4%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintained: Buy | $230 | $199.05 | +15.55% | 31 | Jul 22, 2026 | |
| BRKR Bruker | Maintained: Hold | $44 → $60 | $62.91 | -4.63% | 30 | Jul 8, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $265 | $240.43 | +10.22% | 24 | Jul 8, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,550 | $1,388.38 | +11.64% | 19 | Jul 8, 2026 | |
| QDEL QuidelOrtho | Maintained: Hold | $13 → $18 | $16.67 | +7.98% | 17 | Jul 8, 2026 | |
| GH Guardant Health | Maintained: Buy | $150 → $215 | $143.62 | +49.70% | 23 | Jul 8, 2026 | |
| AVTR Avantor | Maintained: Hold | $9 → $11 | $12.42 | -11.43% | 24 | Jul 8, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $24 → $45 | $47.05 | -4.36% | 27 | Jul 8, 2026 | |
| STVN Stevanato Group | Maintained: Buy | $26 | $20.15 | +29.03% | 12 | Jul 8, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $70 → $73 | $72.07 | +1.29% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $140 → $165 | $180.24 | -8.46% | 20 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $252.22 | +18.94% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $17.76 | +29.50% | 13 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.70 | - | 13 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $28 | $15.59 | +79.60% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $55 | $40.51 | +35.77% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $41 → $95 | $192.98 | -50.77% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $38 | $42.28 | -10.12% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 → $400 | $337.00 | +18.69% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $331.00 | -9.37% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $383.90 | +10.71% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $242.94 | -17.68% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $685 | $576.41 | +18.84% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $140.54 | +31.64% | 37 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $215 | $235.94 | -8.88% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 | $314.23 | +3.43% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $111.51 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $6 | $4.02 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $4.25 | $2.03 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $26.29 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $11.88 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 → $36 | $22.52 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $5.32 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 | $0.0005 | n/a | 1 | Nov 30, 2018 |
Danaher
Jul 22, 2026
Maintained: Buy
Price Target: $230
Current: $199.05
Upside: +15.55%
Bruker
Jul 8, 2026
Maintained: Hold
Price Target: $44 → $60
Current: $62.91
Upside: -4.63%
Charles River Laboratories International
Jul 8, 2026
Maintained: Buy
Price Target: $265
Current: $240.43
Upside: +10.22%
Mettler-Toledo International
Jul 8, 2026
Maintained: Buy
Price Target: $1,550
Current: $1,388.38
Upside: +11.64%
QuidelOrtho
Jul 8, 2026
Maintained: Hold
Price Target: $13 → $18
Current: $16.67
Upside: +7.98%
Guardant Health
Jul 8, 2026
Maintained: Buy
Price Target: $150 → $215
Current: $143.62
Upside: +49.70%
Avantor
Jul 8, 2026
Maintained: Hold
Price Target: $9 → $11
Current: $12.42
Upside: -11.43%
10x Genomics
Jul 8, 2026
Maintained: Hold
Price Target: $24 → $45
Current: $47.05
Upside: -4.36%
Stevanato Group
Jul 8, 2026
Maintained: Buy
Price Target: $26
Current: $20.15
Upside: +29.03%
Bio-Techne
Jun 29, 2026
Downgraded: Hold
Price Target: $70 → $73
Current: $72.07
Upside: +1.29%
Jun 25, 2026
Rated: Hold
Price Target: $140 → $165
Current: $180.24
Upside: -8.46%
May 28, 2026
Maintained: Buy
Price Target: $300
Current: $252.22
Upside: +18.94%
May 28, 2026
Maintained: Buy
Price Target: $23
Current: $17.76
Upside: +29.50%
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.70
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $35 → $28
Current: $15.59
Upside: +79.60%
May 6, 2026
Maintained: Buy
Price Target: $60 → $55
Current: $40.51
Upside: +35.77%
May 4, 2026
Rated: Sell
Price Target: $41 → $95
Current: $192.98
Upside: -50.77%
Apr 29, 2026
Maintained: Hold
Price Target: $55 → $38
Current: $42.28
Upside: -10.12%
Apr 24, 2026
Maintained: Buy
Price Target: $375 → $400
Current: $337.00
Upside: +18.69%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $331.00
Upside: -9.37%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $383.90
Upside: +10.71%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $242.94
Upside: -17.68%
Apr 6, 2026
Maintained: Buy
Price Target: $685
Current: $576.41
Upside: +18.84%
Mar 11, 2026
Maintained: Buy
Price Target: $185
Current: $140.54
Upside: +31.64%
Feb 11, 2026
Maintained: Hold
Price Target: $215
Current: $235.94
Upside: -8.88%
Jan 2, 2026
Maintained: Buy
Price Target: $325
Current: $314.23
Upside: +3.43%
May 22, 2025
Maintained: Buy
Price Target: $135
Current: $111.51
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $9 → $6
Current: $4.02
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: $1.5 → $4.25
Current: $2.03
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $62
Current: $26.29
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $6
Current: $11.88
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $32 → $36
Current: $22.52
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $5.32
Upside: n/a
Nov 30, 2018
Maintained: Hold
Price Target: $4.5
Current: $0.0005
Upside: n/a